MAESTrO: PHARMAC decision relating to a number of respiratory products

Posted by Michael Wonder on 03 Feb 2016

PHARMAC decision relating to a number of respiratory products

3 February 2016 - PHARMAC is pleased to announce the approval of agreements with Boehringer Ingleheim and GlaxoSmithKline involving a number of respiratory products.

For more details, go to: http://www.pharmac.govt.nz/news/notification-2016-02-03-respiratory-products/

Posted by:

Michael Wonder

Posted in:

Outcome , Medicine , Combination product , New Zealand